Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Eder

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Current Oncology (Toronto, Ont.)|April 27, 2026
Robotic Partial Cystectomy and Extended Pelvic Lymph Node Dissection for Node-Positive Urachal Adenocarcinoma in a 34-Year-Old Woman: A Case ReportStefanie Herrmann, Christian Gilfrich, Stephan Siepmann, et al.
Clinical Genitourinary Cancer|July 16, 2013
Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patientsWolfgang Otto, Stefan Denzinger, Hans-Martin Fritsche, et al.
International Urology and Nephrology|December 31, 2016
WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approachWolfgang Otto, Johannes Breyer, Sonja Herdegen, et al.
European Urology|October 20, 2012
Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinomaHans-Martin Fritsche, Matthias May, Stefan Denzinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 4, 2015
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter studyAlexander Karl, Alexander Buchner, Christiane Tympner, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Current Oncology (Toronto, Ont.)|April 27, 2026
Robotic Partial Cystectomy and Extended Pelvic Lymph Node Dissection for Node-Positive Urachal Adenocarcinoma in a 34-Year-Old Woman: A Case ReportStefanie Herrmann, Christian Gilfrich, Stephan Siepmann, et al.
Clinical Genitourinary Cancer|July 16, 2013
Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patientsWolfgang Otto, Stefan Denzinger, Hans-Martin Fritsche, et al.
International Urology and Nephrology|December 31, 2016
WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approachWolfgang Otto, Johannes Breyer, Sonja Herdegen, et al.
European Urology|October 20, 2012
Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinomaHans-Martin Fritsche, Matthias May, Stefan Denzinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 4, 2015
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter studyAlexander Karl, Alexander Buchner, Christiane Tympner, et al.
Pageof 2